Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Other Non Operating Income (2020 - 2025)

Historic Other Non Operating Income for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to $223000.0.

  • Insight Molecular Diagnostics' Other Non Operating Income rose 32075.47% to $223000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $651000.0, marking a year-over-year increase of 1128.21%. This contributed to the annual value of $462000.0 for FY2024, which is 1725.89% up from last year.
  • As of Q3 2025, Insight Molecular Diagnostics' Other Non Operating Income stood at $223000.0, which was up 32075.47% from $125000.0 recorded in Q2 2025.
  • Insight Molecular Diagnostics' Other Non Operating Income's 5-year high stood at $1.1 million during Q2 2021, with a 5-year trough of -$371000.0 in Q4 2022.
  • In the last 5 years, Insight Molecular Diagnostics' Other Non Operating Income had a median value of $117500.0 in 2024 and averaged $134944.4.
  • As far as peak fluctuations go, Insight Molecular Diagnostics' Other Non Operating Income plummeted by 190000.0% in 2022, and later skyrocketed by 1540000.0% in 2024.
  • Insight Molecular Diagnostics' Other Non Operating Income (Quarter) stood at -$8000.0 in 2021, then crashed by 4537.5% to -$371000.0 in 2022, then skyrocketed by 172.51% to $269000.0 in 2023, then tumbled by 45.72% to $146000.0 in 2024, then surged by 52.74% to $223000.0 in 2025.
  • Its Other Non Operating Income stands at $223000.0 for Q3 2025, versus $125000.0 for Q2 2025 and $157000.0 for Q1 2025.